|
12 Sep 2013 |
Coronado Biosciences Announces Initiation of Phase 2 Study Evaluating TSO in Ulcerative Colitis
|
|
11 Sep 2013 |
Kiadis Pharma Completes Five-year Follow-up of its Phase I/II Clinical Study with Blood Cancer Product ATIR™ and Study Meets Primary Objective
|
|
10 Sep 2013 |
First Patient Treated In Phase II Of Neuralstem ALS Stem Cell
|
|
09 Sep 2013 |
Oncolytics Biotech® Inc. Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer
|
|
06 Sep 2013 |
Cellular Biomedicine Group Announces Positive Interim Results from Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)
|
|
06 Sep 2013 |
Prosensa Initiates First Patient Dosing in Phase I/II trial of PRO053
|
|
05 Sep 2013 |
Adynxx Completes Patient Enrollment in Phase 2 Clinical Study of Lead Therapeutic for Prevention of Pain, AYX1
|
|
04 Sep 2013 |
SanBio Announces The Completion Of Enrollment Of Its Clinical Trial Of Cell Therapy For Chronic Stroke Deficits
|
|
31 Aug 2013 |
Isis Reports Interim Phase 2 Data on ISIS-APOCIII Rx as a Single Agent in Patients With Very High to Severely High Triglycerides
|
